Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Gershon

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Bipolar Disorders|January 8, 2017
Journal expansion: Bipolar Big Bang to events on the horizonGin S Malhi, K N Roy Chengappa, Samuel Gershon
Bipolar Disorders|October 31, 2012
A new 'face' for bipolar disorders?Samuel Gershon, K N Roy Chengappa, Gin S Malhi
Bipolar Disorders|November 17, 2011
Atypical mood stabilizers: a new role for neuroleptics?Gin S Malhi, K N Roy Chengappa, Samuel Gershon, et al.
Bipolar Disorders|December 24, 2010
Hypomania: hype or mania?Gin S Malhi, K N Roy Chengappa, Samuel Gershon, et al.
Bipolar Disorders|July 29, 2008
Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for changeAnabel Martinez-Arán, Eduard Vieta, K N Roy Chengappa, et al.
Bipolar Disorders|March 24, 2016
The Lithium Battery: assessing the neurocognitive profile of lithium in bipolar disorderGin S Malhi, Claire McAulay, Samuel Gershon, et al.
The International Journal of Neuropsychopharmacology|September 24, 2004
Effect of intraperitoneal acetyl-L-carnitine (ALCAR) on anxiety-like behaviours in ratsJoseph Levine, Zeev Kaplan, Jay W Pettegrew, et al.
Bipolar Disorders|June 6, 2002
31P-MRS study of acetyl-L-carnitine treatment in geriatric depression: preliminary resultsJay W Pettegrew, Joseph Levine, Samuel Gershon, et al.
Bipolar Disorders|March 27, 2003
Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar maniaK N Roy Chengappa, Robert W Baker, Lixin Shao, et al.
Bipolar Disorders|July 1, 2004
The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtypeRanita Basu, Jaspreet S Brar, K N Roy Chengappa, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Bipolar Disorders|January 8, 2017
Journal expansion: Bipolar Big Bang to events on the horizonGin S Malhi, K N Roy Chengappa, Samuel Gershon
Bipolar Disorders|October 31, 2012
A new 'face' for bipolar disorders?Samuel Gershon, K N Roy Chengappa, Gin S Malhi
Bipolar Disorders|November 17, 2011
Atypical mood stabilizers: a new role for neuroleptics?Gin S Malhi, K N Roy Chengappa, Samuel Gershon, et al.
Bipolar Disorders|December 24, 2010
Hypomania: hype or mania?Gin S Malhi, K N Roy Chengappa, Samuel Gershon, et al.
Bipolar Disorders|July 29, 2008
Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for changeAnabel Martinez-Arán, Eduard Vieta, K N Roy Chengappa, et al.
Bipolar Disorders|March 24, 2016
The Lithium Battery: assessing the neurocognitive profile of lithium in bipolar disorderGin S Malhi, Claire McAulay, Samuel Gershon, et al.
The International Journal of Neuropsychopharmacology|September 24, 2004
Effect of intraperitoneal acetyl-L-carnitine (ALCAR) on anxiety-like behaviours in ratsJoseph Levine, Zeev Kaplan, Jay W Pettegrew, et al.
Bipolar Disorders|June 6, 2002
31P-MRS study of acetyl-L-carnitine treatment in geriatric depression: preliminary resultsJay W Pettegrew, Joseph Levine, Samuel Gershon, et al.
Bipolar Disorders|March 27, 2003
Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar maniaK N Roy Chengappa, Robert W Baker, Lixin Shao, et al.
Bipolar Disorders|July 1, 2004
The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtypeRanita Basu, Jaspreet S Brar, K N Roy Chengappa, et al.
Pageof 3